PURPOSE: To determine the feasibility of daily titration of the neurally adjusted ventilatory assist (NAVA) level in relation to the maximal diaphragmatic electrical activity (EAdi(maxSBT)) measured during a spontaneous breathing trial (SBT) during pressure support ventilation (PSV). METHODS: The study included 15 consecutive patients in whom mechanical ventilation weaning was initiated with the NAVA mode. EAdi(maxSBT) was determined daily during an SBT using PSV with 7 cmH2O of inspiratory pressure and no positive end-expiratory pressure (PEEP). If the SBT was unsuccessful, NAVA was used and the level was then adjusted to obtain an EAdi of ~60% of the EAdi(maxSBT). Arterial blood gas analyses were performed 20 min after each change in NAVA level. RESULTS: Three patients were dropped from the study at day 4 because of worsening of their sickness. The median duration of NAVA ventilation was 4.5 days (IQR 3-6.5). From day 1 to extubation, EAdi(maxSBT) and EAdi increased significantly from 16.6 (9.6) to 21.7 (10.3) μV (P = 0.013) and from 10.0 (5.5) to 15.1 (9.2) μV (P = 0.026), respectively. The pressure delivered significantly decreased from 20 (8) to 10 (5) cmH2O (P = 0.003). Conversely, tidal volume, carbon dioxide tension, and pH values remained unchanged during the same period. CONCLUSION: These results suggest that daily titration of NAVA level with an electrical goal of ~60% EAdi(maxSBT) is feasible and well tolerated. The respiratory mechanics improvement and increase in respiratory drive allowed for a daily reduction of the NAVA level while preserving breathing, oxygenation, and alveolar ventilation until extubation.
PURPOSE: To determine the feasibility of daily titration of the neurally adjusted ventilatory assist (NAVA) level in relation to the maximal diaphragmatic electrical activity (EAdi(maxSBT)) measured during a spontaneous breathing trial (SBT) during pressure support ventilation (PSV). METHODS: The study included 15 consecutive patients in whom mechanical ventilation weaning was initiated with the NAVA mode. EAdi(maxSBT) was determined daily during an SBT using PSV with 7 cmH2O of inspiratory pressure and no positive end-expiratory pressure (PEEP). If the SBT was unsuccessful, NAVA was used and the level was then adjusted to obtain an EAdi of ~60% of the EAdi(maxSBT). Arterial blood gas analyses were performed 20 min after each change in NAVA level. RESULTS: Three patients were dropped from the study at day 4 because of worsening of their sickness. The median duration of NAVA ventilation was 4.5 days (IQR 3-6.5). From day 1 to extubation, EAdi(maxSBT) and EAdi increased significantly from 16.6 (9.6) to 21.7 (10.3) μV (P = 0.013) and from 10.0 (5.5) to 15.1 (9.2) μV (P = 0.026), respectively. The pressure delivered significantly decreased from 20 (8) to 10 (5) cmH2O (P = 0.003). Conversely, tidal volume, carbon dioxide tension, and pH values remained unchanged during the same period. CONCLUSION: These results suggest that daily titration of NAVA level with an electrical goal of ~60% EAdi(maxSBT) is feasible and well tolerated. The respiratory mechanics improvement and increase in respiratory drive allowed for a daily reduction of the NAVA level while preserving breathing, oxygenation, and alveolar ventilation until extubation.
Authors: Christer Sinderby; Jennifer Beck; Jadranka Spahija; Michel de Marchie; Jacques Lacroix; Paolo Navalesi; Arthur S Slutsky Journal: Chest Date: 2007-03 Impact factor: 9.410
Authors: Andrés Esteban; Niall D Ferguson; Maureen O Meade; Fernando Frutos-Vivar; Carlos Apezteguia; Laurent Brochard; Konstantinos Raymondos; Nicolas Nin; Javier Hurtado; Vinko Tomicic; Marco González; José Elizalde; Peter Nightingale; Fekri Abroug; Paolo Pelosi; Yaseen Arabi; Rui Moreno; Manuel Jibaja; Gabriel D'Empaire; Fredi Sandi; Dimitros Matamis; Ana María Montañez; Antonio Anzueto Journal: Am J Respir Crit Care Med Date: 2007-10-25 Impact factor: 21.405
Authors: J-M Boles; J Bion; A Connors; M Herridge; B Marsh; C Melot; R Pearl; H Silverman; M Stanchina; A Vieillard-Baron; T Welte Journal: Eur Respir J Date: 2007-05 Impact factor: 16.671
Authors: Jadranka Spahija; Michel de Marchie; Martin Albert; Patrick Bellemare; Stéphane Delisle; Jennifer Beck; Christer Sinderby Journal: Crit Care Med Date: 2010-02 Impact factor: 7.598
Authors: Lukas Brander; Howard Leong-Poi; Jennifer Beck; Fabrice Brunet; Stuart J Hutchison; Arthur S Slutsky; Christer Sinderby Journal: Chest Date: 2008-11-18 Impact factor: 9.410
Authors: Timothy D Girard; John P Kress; Barry D Fuchs; Jason W W Thomason; William D Schweickert; Brenda T Pun; Darren B Taichman; Jan G Dunn; Anne S Pohlman; Paul A Kinniry; James C Jackson; Angelo E Canonico; Richard W Light; Ayumi K Shintani; Jennifer L Thompson; Sharon M Gordon; Jesse B Hall; Robert S Dittus; Gordon R Bernard; E Wesley Ely Journal: Lancet Date: 2008-01-12 Impact factor: 79.321
Authors: Daniel Tuchscherer; Werner J Z'graggen; Christina Passath; Jukka Takala; Christer Sinderby; Lukas Brander Journal: Intensive Care Med Date: 2011-11-03 Impact factor: 17.440
Authors: Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2012-02-14 Impact factor: 17.440
Authors: Rosa Di Mussi; Savino Spadaro; Lucia Mirabella; Carlo Alberto Volta; Gabriella Serio; Francesco Staffieri; Michele Dambrosio; Gilda Cinnella; Francesco Bruno; Salvatore Grasso Journal: Crit Care Date: 2016-01-05 Impact factor: 9.097
Authors: Elena Spinelli; Tommaso Mauri; Jeremy R Beitler; Antonio Pesenti; Daniel Brodie Journal: Intensive Care Med Date: 2020-02-03 Impact factor: 17.440
Authors: Hodane Yonis; Laure Crognier; Jean-Marie Conil; Isabelle Serres; Antoine Rouget; Marie Virtos; Pierre Cougot; Vincent Minville; Olivier Fourcade; Bernard Georges Journal: BMC Anesthesiol Date: 2015-08-08 Impact factor: 2.217
Authors: Juliana C Ferreira; Fabia Diniz-Silva; Henrique T Moriya; Adriano M Alencar; Marcelo B P Amato; Carlos R R Carvalho Journal: BMC Pulm Med Date: 2017-11-07 Impact factor: 3.317